Differentiation of spontaneous and induced mammary adenocarcinomas of the rat by gene expression profiling

Heike Marxfeld1, Olivier Grenet, Josiane Bringel

  • 1Preclinical Safety, Novartis Pharma AG, Basel, Switzerland. heike.marxfeld@eur.crl.com

Related Concept Videos